BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 6425440)

  • 1. Some complications of the therapy of classic hemophilia.
    Ratnoff OD
    J Lab Clin Med; 1984 May; 103(5):653-9. PubMed ID: 6425440
    [No Abstract]   [Full Text] [Related]  

  • 2. AIDS and preventive treatment in hemophilia.
    Desforges JF
    N Engl J Med; 1983 Jan; 308(2):94-5. PubMed ID: 6216409
    [No Abstract]   [Full Text] [Related]  

  • 3. The management of musculoskeletal problems in hemophilia. Part I. Principles of medical management of hemophilia.
    McMillan CW; Greene WB; Blatt PM; White GC; Roberts HR
    Instr Course Lect; 1983; 32():210-6. PubMed ID: 6443730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coincident classic hemophilia and "idiopathic" thrombocytopenic purpura in patients under treatment with concentrates of antihemophilic factor (factor VIII).
    Ratnoff OD; Menitove JE; Aster RH; Lederman MM
    N Engl J Med; 1983 Feb; 308(8):439-42. PubMed ID: 6401839
    [No Abstract]   [Full Text] [Related]  

  • 5. T-lymphocyte subpopulations in patients with classic hemophilia treated with cryoprecipitate and lyophilized concentrates.
    Menitove JE; Aster RH; Casper JT; Lauer SJ; Gottschall JL; Williams JE; Gill JC; Wheeler DV; Piaskowski V; Kirchner P; Montgomery RR
    N Engl J Med; 1983 Jan; 308(2):83-6. PubMed ID: 6401196
    [No Abstract]   [Full Text] [Related]  

  • 6. Factor VIII/von Willebrand factor replacement therapy. Problems and challenges.
    Aledort LM
    Ann N Y Acad Sci; 1987; 509():49-52. PubMed ID: 3122619
    [No Abstract]   [Full Text] [Related]  

  • 7. [HIV and ethics--information and disinformation].
    Högman C
    Lakartidningen; 1992 Oct; 89(41):3341-2. PubMed ID: 1435026
    [No Abstract]   [Full Text] [Related]  

  • 8. AIDS. Epidemiology update.
    Bennett JA
    Am J Nurs; 1985 Sep; 85(9):968-72. PubMed ID: 2994475
    [No Abstract]   [Full Text] [Related]  

  • 9. What is the importance of the 'small pool concept' in the preparation of fraciton I and cryoprecipitates for the prevention of post-transfusion hepatitis?
    Vox Sang; 1980 Feb; 38(2):106-19. PubMed ID: 6773242
    [No Abstract]   [Full Text] [Related]  

  • 10. [Transfusion therapy of hemophilia A and B].
    Egli H
    Bibl Haematol; 1967; 27():204-10. PubMed ID: 5595089
    [No Abstract]   [Full Text] [Related]  

  • 11. AIDS: a problem for the transfusion service?
    Barbara JA; Contreras M; Hewitt P
    Br J Hosp Med; 1986 Sep; 36(3):178-84. PubMed ID: 3094615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion and coagulation factor-acquired human immunodeficiency virus infection.
    Eyster ME
    Pediatr Infect Dis J; 1991 Jan; 10(1):50-6. PubMed ID: 2003056
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy-induced hepatitis risk in hemophilia patients].
    Schiller WG; Renger FG
    Z Arztl Fortbild (Jena); 1983; 77(19):807-10. PubMed ID: 6417919
    [No Abstract]   [Full Text] [Related]  

  • 14. Acquired hemolytic anemia and thrombocytopenia (Evans' syndrome) in hemophilia.
    Harris PJ; Kessler CM; Lessin LS
    N Engl J Med; 1983 Jul; 309(1):50. PubMed ID: 6406894
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemophilia and acquired immune deficiency syndrome.
    Levine PH; Brettler DB; Sullivan JL
    Prog Clin Biol Res; 1985; 182():287-96. PubMed ID: 2994104
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cryoprecipitate should have preference over factor VIII concentrate in the treatment of patients with hemophilia A].
    Kunst VA; Nováková IR; Haanen C
    Ned Tijdschr Geneeskd; 1989 Jun; 133(23):1163-6. PubMed ID: 2501689
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of the hereditary coagulation disorders.
    Mason DY; Ingram GI
    Semin Hematol; 1971 Apr; 8(2):158-88. PubMed ID: 5313347
    [No Abstract]   [Full Text] [Related]  

  • 18. [T-lymphocyte subpopulations in hemophiliacs and other groups at risk for the acquired immunodeficiency syndrome (AIDS)].
    Gallart T
    Med Clin (Barc); 1984 Oct; 83(12):492-6. PubMed ID: 6096646
    [No Abstract]   [Full Text] [Related]  

  • 19. Physiologic considerations in the management of hemophilia.
    Briggs DK
    Pathobiol Annu; 1971; 1():205-14. PubMed ID: 4950380
    [No Abstract]   [Full Text] [Related]  

  • 20. Estimation of the probability of post transfusion hepatitis in hemophilia treatment.
    Davis CE; Grizzle JE; Bryan JA
    Biometrics; 1973 Jun; 29(2):386-92. PubMed ID: 4709517
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.